Xilio Therapeutics Inc (NASDAQ:XLO) traded at $0.70 at close of the session on Monday, June 02 and made a downward move of -34.57% on its previous day’s price. Xilio Therapeutics Inc has a market cap of $36.25 million and is expected to release its quarterly
Xilio Therapeutics Inc (NASDAQ:XLO) shares, rose in value, with the stock price up by 8.91% to the previous day’s close as strong demand from buyers drove the stock to $1.05. Actively observing the price movement in the recent trading, the stock is buoying the session
Xilio Therapeutics Inc (NASDAQ:XLO) concluded the trading at $0.86 on Friday, May 16 with a rise of 7.42% from its closing price on previous day. Considering stock’s 52-week price range provides that XLO hit a high price of $1.70 and saw its price falling to
Xilio Therapeutics Inc (NASDAQ:XLO) traded at $1.15 at close of the session on Tuesday, May 13 and made an upward move of 57.32% on its previous day’s price. Xilio Therapeutics Inc has a market cap of $59.55 million and is expected to release its quarterly
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.